Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Rectal cancer radiotherapy.

Shelileah Ramsey1, Joel E Tepper

  • 1Department of Radiation Oncology, University of North Carolina School of Medicine, UNC/Lineberger Clinical Cancer Center, Chapel Hill, NC 27599-7512, USA. sramsey@unch.unc.edu

Cancer Journal (Sudbury, Mass.)
|July 11, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Overall Survival Among Patients With Hepatocellular Carcinoma Treated With External Beam Radiation Therapy: Individual Patient Data Outcomes From a Multinational Cohort.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026
Same author

Author Correction: Organ-specific metastases obtained by culturing colorectal cancer cells on tissue-specific decellularized scaffolds.

Nature biomedical engineering·2025
Same author

Erratum to: Defining Minimum Treatment Parameters of Ablative Radiation Therapy in Patients With Hepatocellular Carcinoma: An Expert Consensus. Yanagihara TK, Tepper JE, Moon AM, et al. Pract Radiat Oncol. 2024 Mar-Apr;14(2):134-145.

Practical radiation oncology·2025
Same author

Association between tumor location and toxicity outcomes after stereotactic radiosurgery for brain metastases.

Journal of neuro-oncology·2024
Same author

Don't CUT: Respecting the Potency of Radiation.

International journal of radiation oncology, biology, physics·2024
Same author

What You See Ain't Necessarily What You Got.

International journal of radiation oncology, biology, physics·2024

Adjuvant therapy for rectal cancer has evolved significantly. Combining radiation and chemotherapy improves outcomes for locally advanced disease, enhancing survival and local control.

Area of Science:

  • Oncology
  • Surgical Oncology
  • Radiation Oncology

Background:

  • Rectal cancer treatment has evolved over 30 years with advances in surgery, radiation, and systemic therapy.
  • Historically, abdominoperineal resection and colostomy were common, but sphincter-preserving surgeries are now more feasible.
  • Local recurrence was a major challenge, addressed by total mesorectal excision (TME) and improved systemic therapies.

Purpose of the Study:

  • To review the evolution of adjuvant therapy for rectal cancer.
  • To highlight the impact of multimodality treatment on local control and survival.
  • To discuss future directions in rectal cancer management.

Main Methods:

  • Review of historical and current treatment paradigms for rectal cancer.

Related Experiment Videos

  • Analysis of the role of radiation therapy and systemic chemotherapy.
  • Discussion of surgical advancements like total mesorectal excision.

    • Main Results:

    • Adjuvant radiation therapy improved local control and survival, enabling sphincter preservation.
    • Total mesorectal excision enhanced local control and facilitated sphincter preservation.
    • Addition of chemotherapy to surgery and radiation significantly improves outcomes, especially for locally advanced disease.

    Conclusions:

    • Multimodality therapy, including concurrent chemoradiation, is crucial for locally advanced rectal cancer.
    • Future research focuses on improved diagnostics and novel combinations of radiation sensitizers and systemic agents.
    • Optimizing adjuvant therapy aims to improve local control, survival, and potentially minimize surgical extent.